Biostatistics Core
$103,411P01FY2024CANIH
Dana-Farber Cancer Inst, Boston MA
Investigators
Linked publications & trials
Paper 39475509Paper 39386645Paper 39321798Paper 39075252Paper 38996460Paper 38905635Paper 38889153Paper 38829615Paper 38819218Paper 38610997Paper 38571944Paper 38538860Paper 38518098Paper 38442309Paper 38394203Paper 38357791Paper 38331415Paper 38271660Paper 38218188Paper 38197938Paper 38167262Paper 38165043Paper 38150184Paper 38096371Paper 38052038Paper 38010951Paper 37931207Paper 37909388Paper 37881837Paper 37873358Paper 37648862Paper 37595362Paper 37591951Paper 37483562Paper 37225367Paper 37197843Paper 36922589Paper 36763538Paper 36455613Paper 36453519Paper 36287540Paper 36264143Paper 36108743Paper 35922444Paper 35853853Paper 35773251Paper 35767897Paper 35763353Paper 35714308Paper 35534777Paper 35512188Paper 35447071Paper 35289704Paper 35245435Paper 35185150Paper 35140175Paper 35015684Paper 34921959Paper 34875037Paper 34855941Paper 34698806Paper 34663986Paper 34614506Paper 34582559Paper 34568833Paper 34551505Paper 34531254Paper 34473244Paper 34465866Paper 34348451Paper 34342642Paper 34027417Paper 34019641Paper 33879367Paper 33872011Paper 33854168Paper 33837971Paper 33753942Paper 33730585Paper 33720354Paper 33690798Paper 33547048Paper 33512474Paper 33408186Paper 33406418Paper 33384686Paper 33371192Paper 33217342Paper 33208943Paper 33015529Paper 32961550Paper 32822472Paper 32606137Paper 32559456Paper 32559428Paper 32533060Paper 32494016Paper 32478814Paper 32407673Paper 32232484
Abstract
Core 2 Biostatisics Project Summary/Abstract The purpose of Core 2 Biostatistics is to provide statistical support to the four Projects as well as to the initiatives involving clinical studies through Core 3 and statistical assessment of biospecimens through Core 1, all toward the goal of development of curative options for patients with AML, MDS, and CMML. This Core assures that the design, conduct, and analyses of all experimentsâclinical, correlative, animal, or basic science- -use robust statistical techniques that are appropriately implemented. This central resource thereby helps to elucidate the mechanisms as well as the vulnerabilities of myeloid malignancies.
View original record on NIH RePORTER →